REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $159,160 | +17.1% | 1,561 | +4.4% | 0.01% | +14.3% |
| Q1 2023 | $135,925 | +100.4% | 1,495 | -16.2% | 0.01% | +133.3% |
| Q4 2022 | $67,812 | +51.2% | 1,785 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $44,857 | -17.3% | 1,785 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $54,246 | -7.2% | 1,785 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $58,477 | -70.6% | 1,785 | -76.3% | 0.00% | -33.3% |
| Q4 2021 | $198,803 | -73.8% | 7,539 | 0.0% | 0.00% | -72.7% |
| Q3 2021 | $758,499 | -28.8% | 7,539 | +0.1% | 0.01% | -26.7% |
| Q2 2021 | $1,065,862 | +508.8% | 7,531 | +328.9% | 0.02% | +400.0% |
| Q1 2021 | $175,073 | -15.8% | 1,756 | +4.4% | 0.00% | 0.0% |
| Q4 2020 | $207,929 | +24.5% | 1,682 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $167,075 | -38.3% | 1,715 | -1.2% | 0.00% | -40.0% |
| Q2 2020 | $270,851 | -72.7% | 1,736 | -74.8% | 0.01% | -76.2% |
| Q1 2020 | $993,059 | -28.6% | 6,880 | +1.1% | 0.02% | -8.7% |
| Q4 2019 | $1,391,759 | +162.7% | 6,808 | +3.2% | 0.02% | +155.6% |
| Q3 2019 | $529,834 | -9.1% | 6,599 | +6.8% | 0.01% | -10.0% |
| Q2 2019 | $583,083 | +12.4% | 6,180 | +1.8% | 0.01% | +11.1% |
| Q1 2019 | $518,888 | +52.4% | 6,071 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $340,583 | -31.4% | 6,071 | 0.0% | 0.01% | -22.2% |
| Q3 2018 | $496,365 | -99.7% | 6,071 | +11.2% | 0.01% | +200.0% |
| Q2 2018 | $190,936,000 | +161.3% | 5,460 | +53.2% | 0.00% | +200.0% |
| Q1 2018 | $73,077,000 | +72253.5% | 3,563 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $101,000 | -50.0% | 3,563 | -45.1% | 0.00% | 0.0% |
| Q3 2017 | $202,000 | -1.5% | 6,492 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $205,000 | – | 6,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |